These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1663572)

  • 1. Influence of aztreonam-netilmicin association on outer membrane proteins of P. aeruginosa strains.
    Cipriani P; Giordano A; Magni A; Filadoro F
    Microbiologica; 1991 Oct; 14(4):301-5. PubMed ID: 1663572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs.
    Giordano A; Magni A; Trancassini M; Cipriani P
    New Microbiol; 1993 Jul; 16(3):281-6. PubMed ID: 8366824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of combinations of netilmicin with aztreonam against Pseudomonas aeruginosa.
    Tumah H; Velonaki A; Michalitsianos D; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):128-9. PubMed ID: 3151332
    [No Abstract]   [Full Text] [Related]  

  • 4. Postantibiotic effect of norfloxacin and its influence on profiles of outer membrane proteins of Pseudomonas aeruginosa.
    Hostacká A; Karelová E
    Pharmazie; 1997 Mar; 52(3):238-9. PubMed ID: 9109171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa.
    Champlin FR; Ellison ML; Bullard JW; Conrad RS
    Int J Antimicrob Agents; 2005 Aug; 26(2):159-164. PubMed ID: 16040235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
    Hostacká A; Karelová E
    Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa.
    Nakae T
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using nanoparticle optics assay for direct observation of the function of antimicrobial agents in single live bacterial cells.
    Kyriacou SV; Brownlow WJ; Xu XH
    Biochemistry; 2004 Jan; 43(1):140-7. PubMed ID: 14705939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors.
    Trancassini M; Giordano A; Magni A; Cipriani P
    New Microbiol; 1993 Jul; 16(3):275-9. PubMed ID: 8366823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
    Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
    J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin.
    Flournoy DJ; Cox FR
    Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):487-9. PubMed ID: 6439964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin.
    Maloney J; Rimland D; Stephens DS; Terry P; Whitney AM
    Arch Intern Med; 1989 Mar; 149(3):630-4. PubMed ID: 2493230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
    Cipriani P; Giordano A; Magni A; Papa F; Filadoro F
    Drugs Exp Clin Res; 1995; 21(4):139-44. PubMed ID: 8529526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.